Kim, Y-H; Shim, J; Tsai, C-T; Wang, C-C; Vilela, G; Muengtaweepongsa, S; Kurniawan, M; Maskon, O; Hsu, LF; Nguyen, TH; et al. Kim, Y-H; Shim, J; Tsai, C-T; Wang, C-C; Vilela, G; Muengtaweepongsa, S; Kurniawan, M; Maskon, O; Hsu, LF; Nguyen, TH; Sim, K; Camm, AJ (2019) The New CHEST Guidelines on Antithrombotic Therapy for Atrial Fibrillation Should Consider Recent Data on Rivaroxaban. Chest, 155 (6). pp. 1309-1311. ISSN 1931-3543 https://doi.org/10.1016/j.chest.2019.03.036
SGUL Authors: Camm, Alan John

Microsoft Word (.docx) Accepted Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (62kB)

Item Type:	Article
Additional Information:	© 2019. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
Keywords:	1103 Clinical Sciences, Respiratory System
SGUL Research Institute / Research Centre:	Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title:	Chest
ISSN:	1931-3543
Language:	eng
Dates:	Date Event June 2019 Published 4 June 2019 Published Online 7 March 2019 Accepted
Publisher License:	Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0
PubMed ID:	31174652
Web of Science ID:	WOS:000470109900046
	Go to PubMed abstract
URI:	https://openaccess.sgul.ac.uk/id/eprint/110973
Publisher's version:	https://doi.org/10.1016/j.chest.2019.03.036

Actions (login required)

Edit Item